ProShare Advisors’s Apogee Therapeutics APGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $359K | Sell |
8,265
-1,970
| -19% | -$85.6K | ﹤0.01% | 1324 |
|
|
2025
Q1 | $382K | Sell |
10,235
-2,570
| -20% | -$96K | ﹤0.01% | 1245 |
|
|
2024
Q4 | $580K | Buy |
12,805
+2,985
| +30% | +$135K | ﹤0.01% | 1185 |
|
|
2024
Q3 | $577K | Buy |
9,820
+1,504
| +18% | +$88.3K | ﹤0.01% | 1062 |
|
|
2024
Q2 | $327K | Sell |
8,316
-1,722
| -17% | -$67.8K | ﹤0.01% | 1227 |
|
|
2024
Q1 | $667K | Buy |
+10,038
| New | +$667K | ﹤0.01% | 932 |
|